Oncolytics Biotech
ONCY----
Oncolytics Biotech (ONCY)
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The com...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Oncolytics Biotech Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$5.08525.59%
Forecast & RatingBuy
6analysts
- Strong buy33.33%
- Buy50.00%
- Hold16.67%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 21 hours ago
The Biotech Survival Charade: Stop Buying the "AI Pivot" Hype
- Global Report · 1 day ago, 04:17 AM
Inside the Biotech Sector's Recent Clinical Catalyst Wave
- Global Report · 1 day ago, 04:13 AM
Consumer Resilience Meets Sector Divergence: A Microcosm for Fed Officials
- TradingView · 2 days ago, 03:43 PM
Oncolytics Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard
- Global Report · 2 days ago, 04:13 AM
The AI Pivot Pain: Inside monday.com's Layoffs and the Broader Strategic Overhauls
- Global Report · Jul 22 at 04:18 AM
Columbia Financial's USD 1.7B Raise and Timken's Guidance Hike Lead Mid-2026 Strategic Shifts
